- Home
- RVMD vs SHG Comparison
RVMD vs SHG Comparison
Compare RVMD & SHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVMD | SHG |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | South Korea |
| Employees | 883 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1B | 28.9B |
| IPO Year | N/A | 2003 |
Fundamental Metrics
Financial Performance| Metric | RVMD | SHG |
|---|---|---|
| Price | $161.65 | $66.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 19 | 0 |
| Target Price | ★ $140.84 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 237.2K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.16 |
| Revenue Next Year | $533.02 | $3.88 |
| P/E Ratio | ★ N/A | $9.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.00 | $44.80 |
| 52 Week High | $166.50 | $73.40 |
Technical Indicators
Market Signals| Indicator | RVMD | SHG |
|---|---|---|
| Relative Strength Index (RSI) | 61.78 | 51.56 |
| Support Level | $141.22 | $65.55 |
| Resistance Level | $166.50 | $69.36 |
| Average True Range (ATR) | 6.70 | 1.62 |
| MACD | 0.20 | 0.40 |
| Stochastic Oscillator | 85.99 | 51.61 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About SHG Shinhan Financial Group Co Ltd
Shinhan Financial Group Co Ltd is a Korean banking group. Along with its subsidiaries the company provides, comprehensive financial services which consist of commercial banking services, credit card services, securities services, insurance, credit services, and asset management services, including securities investment trust management, investment advisory, call transaction, domestic and foreign private equity fund business, and other services. The majority of the revenue is generated from its Banking business which includes retail, corporate, international, and other banking services the company offers.